detect possible allergic responses to various substances in the environment
Kappa – Immunofixation, Serum (NMH/LFH) Marker name: Kappa Test panel: Immunofixation, Serum (NMH/LFH) Category: Immunoglobulin Light Chains / Monoclonal Gammopathy Screening What is Kappa? Kappa is one of two types of light chains (the other being lambda) found in immunoglobulins (antibodies), which are proteins produced by plasma cells in the immune system. Each antibody contains two heavy chains and two light chains—either kappa or lambda, but not both. In healthy individuals, kappa and lambda light chains are produced in a balanced ratio. An abnormal increase in one type may indicate the presence of a monoclonal protein (M-protein), a hallmark of certain plasma cell or B-cell disorders. Why is Kappa measured in serum immunofixation? Serum immunofixation electrophoresis (IFE) is used to identify abnormal monoclonal proteins in the blood. By specifically analyzing kappa and lambda light chains in conjunction with different immunoglobulin heavy chains (IgG, IgA, IgM, etc.), the test helps determine whether a monoclonal gammopathy is present, and what type of immunoglobulin is involved. This test is particularly useful for diagnosing and monitoring: Multiple myeloma Monoclonal gammopathy of undetermined significance (MGUS) Waldenström macroglobulinemia Primary amyloidosis (AL) Chronic lymphocytic leukemia (CLL) Other B-cell or plasma cell dyscrasias What does an abnormal Kappa result mean? Increased Kappa light chain (with or without decreased lambda) may indicate a monoclonal kappa light chain-producing clone, often seen in multiple myeloma, MGUS, or related conditions. A monoclonal band (also called an “M-spike”) corresponding to kappa in the presence of a specific heavy chain (e.g., IgG kappa) suggests a clonal population of plasma cells. Suppressed or absent Kappa may be relevant when lambda is elevated, suggesting a monoclonal lambda-producing disorder. The interpretation of kappa results always considers the kappa/lambda ratio, which helps assess the clonality of plasma cells and distinguish between benign polyclonal responses and malignant monoclonal proliferations. What follow-up testing might be needed? If a monoclonal kappa light chain is detected: Serum free light chain (FLC) assay to quantify free kappa and lambda chains and their ratio Serum protein electrophoresis (SPEP) to assess the M-protein concentration Urine immunofixation for Bence Jones protein (free light chains in urine) Bone marrow biopsy to evaluate plasma cell proliferation Imaging to assess for bone lesions (in multiple myeloma) Key takeaways Kappa is a type of immunoglobulin light chain analyzed in serum immunofixation. It helps detect monoclonal gammopathies and determine the type of abnormal antibody produced. Abnormal kappa results—especially with an altered kappa/lambda ratio—can be early markers of plasma cell disorders like multiple myeloma. Interpretation should always be made in the context of clinical findings and additional lab data.
can help diagnose multiple myeloma and other plasma cell dyscrasias
Kappa/Lambda Ratio – What It Means and Why It Matters The Kappa/Lambda ratio is a key marker used to evaluate the balance of free light chains—kappa and lambda—produced by plasma cells in the immune system. These light chains are components of antibodies, and under normal conditions, the body maintains a relatively stable ratio between them. An abnormal kappa/lambda ratio can be a strong indicator of a plasma cell disorder. A high ratio (above the normal range) suggests excess production of kappa light chains, possibly due to kappa-restricted monoclonal gammopathy, such as multiple myeloma or MGUS. A low ratio suggests an excess of lambda light chains, which may indicate lambda-restricted monoclonal gammopathy. When one light chain type is significantly elevated and the ratio is skewed, it usually points to a clonal proliferation of abnormal plasma cells producing only one type of light chain. The Kappa/Lambda ratio is especially useful in conjunction with serum free light chain testing and immunofixation electrophoresis to detect and monitor conditions like multiple myeloma, AL amyloidosis, and other B-cell malignancies.
to help detect, diagnose, and monitor conditions associated with an increased production of free light chains.
help to detect and manage multiple myeloma and other plasma cell disorders
Requires Vitamin B1, B5, lipoic acid, B2, and B3 to be metabolized.
The test measures ketone levels in your urine.
Kidney bean IgG reactivity marker
Elevated antibody levels can be clinically significant